Accent Microcell Ltd
Incorporated on April 10, 2012, Accent Microcell Limited produces high-quality cellulose-based excipients mainly for the Pharmaceutical, Nutraceutical, Food, Cosmetic and other industries[1]
- Market Cap ₹ 561 Cr.
- Current Price ₹ 267
- High / Low ₹ 364 / 224
- Stock P/E 43.1
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 29.3 %
- ROE 34.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.8%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| 131 | 133 | 166 | 204 | |
| 122 | 122 | 153 | 185 | |
| Operating Profit | 9 | 11 | 13 | 19 |
| OPM % | 7% | 8% | 8% | 9% |
| 4 | 2 | 2 | 3 | |
| Interest | 3 | 3 | 3 | 3 |
| Depreciation | 3 | 4 | 4 | 4 |
| Profit before tax | 6 | 6 | 8 | 15 |
| Tax % | 31% | 20% | 22% | 16% |
| 4 | 5 | 6 | 13 | |
| EPS in Rs | 9.72 | 11.16 | 4.56 | 10.05 |
| Dividend Payout % | 0% | 0% | 18% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 46% |
| TTM: | 121% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 26% |
| Last Year: | 34% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|
| Equity Capital | 4 | 13 | 13 | 15 |
| Reserves | 21 | 19 | 31 | 61 |
| 30 | 24 | 23 | 6 | |
| 22 | 38 | 47 | 30 | |
| Total Liabilities | 77 | 95 | 114 | 112 |
| 29 | 30 | 30 | 30 | |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| 48 | 64 | 84 | 82 | |
| Total Assets | 77 | 95 | 114 | 112 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| 5 | 5 | 15 | 8 | |
| -2 | -6 | -4 | -4 | |
| -2 | -2 | -10 | -4 | |
| Net Cash Flow | 1 | -3 | 1 | -1 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Debtor Days | 60 | 38 | 43 | |
| Inventory Days | 78 | 128 | 136 | |
| Days Payable | 80 | 97 | 88 | |
| Cash Conversion Cycle | 58 | 68 | 91 | |
| Working Capital Days | 59 | 54 | 62 | |
| ROCE % | 29% |
Documents
Announcements
Annual reports
No data available.
Business Profile[1] The company manufactures Microcrystalline Cellulose ("MCC"), which is an odorless, fine white powder, a purified form of cellulose that's derived from refinement of highly purified wood pulp and has carved a niche in producing high-quality cellulose-based excipients, that meet international quality standards.